Giang N Nguyen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Giang N Nguyen

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Methods & Clinical Development|January 3, 2022

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia ALiron Elkouby, Sean M Armour, Raffaella Toso, et al.

Nature Biotechnology|November 17, 2020

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.

Science Advances|September 16, 2020

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editingXinfu Zhang, Weiyu Zhao, Giang N Nguyen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Methods & Clinical Development|January 3, 2022

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia ALiron Elkouby, Sean M Armour, Raffaella Toso, et al.

Nature Biotechnology|November 17, 2020

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cellsGiang N Nguyen, John K Everett, Samita Kafle, et al.

Science Advances|September 16, 2020

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editingXinfu Zhang, Weiyu Zhao, Giang N Nguyen, et al.

Pageof 2